1. Nanoparticle-based Olaparib delivery enhances its effect, and improves drug sensitivity to cisplatin in triple negative breast cancer
   Shentao Zhang et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
2. FTO blocks RNA translational activity via the loss of N6‐methyladenosine methylation at 5′ UTR regulated by RBM5 in cisplatin‐resistant NSCLC
   Liantao Li et al, 2024, Journal of Cellular Physiology CrossRef
3. DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review
   Zoe Phan et al, 2023, Pharmacological Research CrossRef
4. PARP Inhibitors and Proteins Interacting with SLX4
   Lars Petter Jordheim, 2023, Cancers CrossRef
5. C,O‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity
   Adrian‐Alexandru Someșan et al, 2022, Applied Organometallic Chemistry CrossRef